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General Information
All chemicals and reagents were purchased from Sigma-Aldrich, Alfa Aesar, Acros, TCI, or ChemImpex. PhI(OAc)2 was ground and dried under high vacuum prior to use. Acetonitrile and triethylamine were distilled over calcium hydride before use. CH2Cl2, THF, and DMF were dried and degassed with nitrogen using an Innovative Technology solvent system. Silicycle F60 (230-400 mesh) silica gel was used or a CombiFlash® Automated Flash Chromatograph for flash column chromatography. Thin layer chromatography (TLC) analyses were performed using Merck silica gel 60 F254 plates and visualized under UV (254 nm), KMnO4, or iodine stain. Melting points were determined using an Electrotherman IA9000. 1 H, 19 F, 13 C NMR spectra were recorded using a Bruker AVIII 400 or AVIII 600 MHz NMR spectrometer.
1 H NMR and 13 C NMR chemical shifts are reported in parts per million and referenced with respect to CDCl3 ( 1 H: residual CHCl3 at δ 7.26, 13 C: CDCl3 triplet at δ 77.16). 1 H NMR data are reported as chemical shifts (δ ppm), multiplicity (s = singlet, bs = broad singlet, d = doublet, t = triplet, q = quartet, quint = quintet, m = multiplet, app t = apparent triplet, app q = apparent quartet, app qd = apparent quartet of doublets), coupling constant (Hz) , relative integral. 19 F NMR data are reported as chemical shifts (δ ppm). High resolution mass spectra were obtained using Bruker MicrOTOF (ESI). IR spectra were recorded using a Thermo Fisher Nicolet iS10 FT-IR and are reported in terms of frequency of absorption (cm-1). Previously reported imidates and amino alcohols were characterized by 1 H and 13 C NMR and matched previous spectra.
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I. General Procedure
Trichloroacetimidate Formation -General Procedure (GP1)
To a round-bottom flask containing a stir bar, alcohol (1 equiv.), and CH2Cl2 (0.1 M) was added trichloroacetonitrile (1.5 equiv.) and DBU (0.1 equiv.). The solution was stirred and monitored by TLC until consumption of alcohol. Upon completion, the solution was concentrated and directly loaded onto silica gel and purified.
Benzimidate Formation -General Procedure (GP2)
To a 50 mL round bottom flask was added benzonitrile (1 equiv.), alcohol (12 equiv.), and a stir bar. The solution was cooled to 0 °C, an addition funnel containing acetyl chloride (8 equiv.) was attached, and the apparatus was sealed. The acetyl chloride was added dropwise over a half an hour and then the solution was warmed to room temperature (warning: HCl gas is evolved during this addition, poorly sealed glassware will allow gas to escape). The reaction was stirred at room temperature for 24 hours and then evaporated under reduced pressure to yield the imidate•HCl salt. Free base protocol. The salt was suspended in Et2O and a saturated solution of NaHCO3 was added dropwise until the salt dissolved completely. Upon dissolution, the solution was stirred for five minutes and then diluted with H2O. The organic phase was separated and the aqueous phase was extracted with Et2O (2 x 10 mL). The combined organic phase was dried over MgSO4 and concentrated. In most cases, the imidate was analytically pure upon isolation. Alternatively, the crude material could be purified by column chromatography.
Benzimidate Formation -General Procedure (GP3)
To a 2-dram vial equipped with a stir bar was added the desired alcohol (1 equiv.) and benzonitrile (1 equiv.) and dry solvent (toluene or dichloroethane, 0.5 M). Triflic acid (1.2 equiv.) was added to the solution, the vial was sealed, and heated to reflux for 24 hours. Upon completion, the vial was cooled to room temperature and evaporated to dryness. The resulting solid was suspended in Et2O and subjected to the free base protocol from GP2. The product was purified by column chromatography.
Transimidation -General Procedure (GP4)
To a 2-dram vial equipped with a stir bar was added the trifluoroethyl benzimidate hydrochloride 1 (1 equiv.), the desired alcohol (1 equiv), and MeCN (0.2 M). The reaction was heated to 50 °C and stirred until consumption of starting imidate (monitored by 1 H NMR). Upon completion, the solution was concentrated and the resulting crude solid was suspended in Et2O and subjected to the free base protocol from GP2. The crude reaction mixture was loaded onto silica gel and purified.
C-H Amination -General Procedure (GP5)
To a 2-dram vial equipped with PTFE septa cap and magnetic stir bar was added imidate (0.4 mmol, 1 equiv.) and PhI(OAc)2 (154.6 mg, 0.48 mmol, 1.2 equiv.). This vial was evacuated and backfilled with N2 (3x). A degassed stock solution of I2 in dry DMF (2 mL, 0.01 M, 0.05 equiv.) was added to the vial under N2. The reaction was heated to 50°C (by placing vial in an aluminum heating block) and stirred for 4 hours. Upon completion, the reaction was cooled, transferred to a round-bottom flask, and concentrated in vacuo. Hydrolysis and acid/base extraction. To the flask, was added methanol (4 mL) and 2M HCl (0.8 mL). After stirring for 2 hours, 25 mL of CHCl3 and 10 mL of H2O was added. The aqueous layer was washed with CHCl3 (5 x 25 mL). The combined organic fractions were rewashed with H2O (10 mL). The combined aqueous layer was poured into a round bottom, diluted with CHCl3 (25 mL), and finally 6M NaOH (10 mL) was added and stirred for 30 minutes. The aqueous layer was washed with CHCl3 (5 x 25 mL) and the combined organic solution was dried over MgSO4 and concentrated to yield the pure amino alcohol.
I 2 Stock Solution (0.01 M in DMF)
To a flame-dried Schlenk flask equipped with a stir bar, was added I2 (50.8 mg, 0.2 mmol) and dry DMF (20 mL). The resulting solution was degassed via a free-pump-thawed protocol three times. The solution was warmed to room temperature under N2 and used directly in the amination protocol. Notes 1. PhI(OAc)2 was ground and dried under vacuum prior to use. 2. To avoid incident light, the stock solution flask was covered with aluminum foil. 3. Large quantities of residual DMF during hydrolysis lead to suppressed isolated yields. 4. Although the reaction is typically complete in one hour, to ensure completion for all substrates the standard reaction time was made four hours.
III. Substrate Synthesis
4-methoxyphenethyl 2,2,2-trichloroacetimidate (S3)
4-methoxyphenethyl alcohol (0.1 g, 0.7 mmol) was subjected to GP1. Following reaction completion, the solvent was removed in vacuo and the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield imidate S3 (0.18 g, 92%) as a colorless solid. Rf: 0.31 (10% Ethyl acetate/hexanes). 1 
4-fluorophenethyl 2,2,2-trichloroacetimidate (S4)
4-fluorophenethyl alcohol (701 mg, 0.625 mL, 5 mmol) was subjected to GP1. Following reaction completion, the solvent was removed in vacuo and the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield imidate S4 (1.42 g, 99%) as a colorless oil. Rf: 0.38 (10% Ethyl acetate/hexanes). 1 
4-(trifluoromethyl)phenethyl 2,2,2-trichloroacetimidate (S5)
4-(trifluoromethyl)phenethyl alcohol (735 mg, 4 mmol) was subjected to GP1. Following reaction completion, the solvent was removed in vacuo and the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield imidate S5 (1.10 g, 83%) as a colorless solid. Rf: 0.25 (10% Ethyl acetate/hexanes).
1 H NMR (600 MHz, CDCl3) δ: 8.32 (bs, 1H), 7.56 (d, J = 7.9 Hz, 2H), 7.40 (d, J = 7.9 Hz, 2H), 4.52 (t, J = 6.6 Hz, 2H), 3.15 (t, J = 7.9 Hz, 2H). 13 
3-methoxyphenethyl 2,2,2-trichloroacetimidate (S6)
2-(3-methoxyphenyl)ethan-1-ol (0.2 g, 1.3 mmol) was subjected to GP1. Following reaction completion, the solvent was removed in vacuo and the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield imidate S6 (0.37 g, 95%) as a clear colorless oil. Rf: 0.36 (10% Ethyl acetate/hexanes). 1 H NMR (400 MHz, CDCl3) δ: 8.29 (bs, 1H), 7.22 (t, J = 7.8 Hz, 1H), 6.88 -6.84 (m, 2H), 6.88 -6.84 (m, 1H), 4.50 (t, J = 6.9 Hz, 2H), 3.80 (s, 3H), 3.07 (t, J = 6.9 Hz, 2H). 13 C NMR (100 MHz, CDCl3) δ: 162.9, 159.8, 139.4, 129.6, 121.5, 114.9, 112.3, 91.6, 69.9, 55.3, 34.9.
3-methylphenethyl 2,2,2-trichloroacetimidate (S7)
2-(3-methylphenyl)ethanol (613 mg, 4.5 mmol) was subjected to GP1. Following reaction completion, the solvent was removed in vacuo and the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield imidate S7 (1.2 g, 95%) as a clear colorless oil. Rf: 0.61 (20% Ethyl acetate/hexanes). 1 H NMR (400 MHz, CDCl3) δ: 8.28 (bs, 1H), 7.20 (t, J = 7.5 Hz, 1H), 7.11 -7.04 (m, 3H), 4.48 (t, J = 6.9 Hz, 2H), 3.06 (t, J = 7.0 Hz, 2H), 2.33 (s, 3H). 13 
2-(trifluoromethyl)phenethyl 2,2,2-trichloroacetimidate (S8)
2-(2-(trifluoromethyl)phenyl)ethan-1-ol was subjected to GP1. After concentration, the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield trichloroacetimidate S8 (1.56 
2-(thiophen-2-yl)ethyl 2,2,2-trichloroacetimidate (S11)
2-(thiophen-2-yl)ethan-1-ol (577 mg, 1.6 mmol) was subjected to GP1. Following reaction completion, the solvent was removed in vacuo and the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield imidate S11 (366 mg, 86%) as a clear colorless oil. Rf: 0.63 (20% Ethyl acetate/hexanes). 1 H NMR (400 MHz, CDCl3) δ: 8.32 (bs, 1H), 7.17 (dd, J = 5.0, 1.4 Hz, 1H), 6.96 -6.92 (m, 2H), 4.51 (t, J = 6.7 Hz, 2H), 3.31 (t, J = 6.7 Hz, 2H). 13 C NMR (100 MHz, CDCl3) δ: 162.9, 139.7, 127.0, 125.9, 124.2, 91.5, 69.6, 29.0.
2-(pyridin-2-yl)ethyl 2,2,2-trichloroacetimidate (S12)
2-(2-pyridyl)ethanol (0.55 g, 0.51 mL, 4.5 mmol) was subjected to GP1. Following reaction completion, the solvent was removed in vacuo and the crude mixture was purified (silica gel, hexanes → 40% ethyl acetate/hexanes) to yield imidate S12 (1.16 
2,3-dihydro-1H-inden-2-yl 2,2,2-trichloroacetimidate (S14)
2,3-dihydro-1H-inden-2-ol was subjected to GP1. After concentration, the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield trichloroacetimidate S14 (1.5 g, 72%) as a low melting solid. Rf: 0.35 (10% Ethyl acetate/hexanes). 1 
1-phenylpropan-2-yl 2,2,2-trichloroacetimidate (S15)
1-phenylpropan-2-ol was subjected to GP1. After concentration, the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield trichloroacetimidate S15 (1.77 
3-trichloroacetimidatyl cholesterol (S16)
Cholesterol (193 mg, 0.5 mmol) was subjected to GP1. Following reaction completion, the solvent was removed in vacuo and the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield imidate S16 (220 mg, 83%) as a white solid. Rf: 0.72 (20% Ethyl acetate/hexanes). 
Pentyl benzimidate (1)
1-pentanol was subjected to GP2. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the freebase protocol, followed by purification (silica gel, hexanes with 1% EtOAc and 1% Et3N) to yield imidate 1 (2.46 g, 80%) as a colorless oil. Rf: 0.31 (20% Ethyl acetate/hexanes). 
4-cyclohexylbutyl benzimidate (S18)
4-cyclohexylbutan-1-ol (569 mg, 0.607 mL, 4 mmol) was subjected to GP3. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the free-base protocol, followed by purification on silica gel (5% Ethyl acetate/hexanes with 1% Et3N) to yield imidate S18 (772 mg, 78%) as a colorless oil. Rf: 0.2 (20% Ethyl acetate/hexanes). 
Sec-butyl benzimidate (S19)
Butan-2-ol (8.60 g, 10.6 mL, 116 mmol) was subjected to GP2. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the free-base protocol, followed by purification on silica gel (5% Ethyl acetate/hexanes with 1% Et3N to yield imidate S19 (300 mg, 22%) as a colorless oil. Rf: 0.31 (20% Ethyl acetate/hexanes). 1 
Cyclopentyl benzimidate (S20)
Cyclopentanol (86 mg, 0.090 mL, 1 mmol) was subjected to GP4. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the free-base protocol, followed by purification on silica gel (5% Ethyl acetate/hexanes with 1% Et3N) to yield imidate S20 (89 mg, 47%) as a colorless oil. Rf: 0.25 (20% Ethyl acetate/hexanes). 
Ethyl benzimidate (S21)
Ethanol (5.36 g, 6.79 mL, 116 mmol) was subjected to GP2. After 24 hours, the mixture was concentrated yielding a white solid. This hydrochloride salt (0.5 g) was subjected to basic workup to yield imidate S21 (0.33 g, 87%) as a colorless oil. Rf: 0.25 (20% Ethyl acetate/hexanes). 
6-chlorohexylbenzimidate (S22)
6-chlorohexan-1-ol (546 mg, 0.534 mL, 4 mmol) was subjected to GP3. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo.
The crude mixture was subjected to the free-base protocol, followed by purification on silica gel (5% Ethyl acetate/hexanes with 1% Et3N to yield imidate S22 (852 mg, 89%) as a colorless oil. 
2-(4-hydroxybutyl)isoindoline-1,3-dione (S23A)
A mixture of 4-amino-1-butanol (445 mg, 5.0 mmol) and phthalic anhydride (740 mg, 5.0 mmol) in toluene (20 mL) was heated to reflux for 3 h. After cooling and removal of solvent, the crude product was purified (50% Ethyl acetate/hexanes) to yield alcohol S23A as a white crystalline solid (1.1 g, 99% yield). Rf: 0.25 (50% Ethyl acetate/hexanes). 
4-(1,3-dioxoisoindolin-2-yl)butyl benzimidate (S23)
2-4-hydroxybutyl)isoindoline-1,3-dione S23A (575 mg, 2.4 mmol) and benzimidate salt (575 mg, 2.4 mmol) were subjected to GP4. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the freebase protocol, followed by purification on silica gel (hexanes to 30% ethyl acetate in hexanes) to yield imidate S23 (352 mg, 91%) as a colorless solid. Rf: 0.31 (hexanes to 30% Ethyl acetate/hexanes). 1 
4,4,4-trifluorobutyl benzimidate (S24)
4,4,4-trifluorobutan-1-ol (512 mg, 0.423 mL, 4 mmol) was subjected to GP3. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the free-base protocol, followed by purification on silica gel (5% Ethyl acetate/hexanes with 1% Et3N) to yield imidate S24 (485 mg, 53%) as a colorless oil. Rf: 0.13 (20% Ethyl acetate/hexanes). 1 
oct-7-en-1-yl benzimidate (S25)
oct-7-en-1-ol (128 mg, 0.152 mL, 1 mmol) was subjected to GP4. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the free-base protocol, followed by purification on silica gel (5% Ethyl acetate/hexanes with 1% Et3N) to yield imidate S25 (185 mg, 80%) as a colorless oil. Rf: 0.28 (20% Ethyl acetate/hexanes). 1 
hex-5-yn-1-yl benzimidate (S26)
hex-5-yn-1-ol (98 mg, 0.110 mL, 1 mmol) was subjected to GP4. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the free-base protocol, followed by purification on silica gel (5% Ethyl acetate/hexanes with 1% Et3N) to yield imidate S26 (219 mg, 100%) as a colorless solid. Rf: 0.13 (20% Ethyl acetate/hexanes). 1 
isopentyl benzimidate (S28)
3-methylbutanol (1.71 g, 2.11 mL, 19.4 mmol) and benzonitrile (1 g, 1 mL, 9.7 mmol) were dissolved in 2.4 mL of HCl in dioxanes (4M, 9.6 mmol). The reaction was stirred for 2 days and then concentrated. The resultant salt was suspended in Et2O and free-based according to GP2 to yield imidate S28 (0.31 g, 17%) as a clear oil. Rf: 0.34 (20% Ethyl acetate/hexanes). 1 
4-methylphenethyl 2,2,2-trichloroacetimidate (S32)
4-methylphenethyl alcohol (719 mg, 0.5 mL, 4.98 mmol) was subjected to GP1. Following reaction completion, the solvent was removed in vacuo and the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield imidate S32 (0.93 g, 53%) as a colorless solid. Rf: 0.38 (10% Ethyl acetate/hexanes).
1 H NMR (400 MHz, CDCl3) δ: 8.27 (bs, 1H), 7.16 (d, J = 7.9 Hz, 2H), 7.11 (d, J = 7.8 Hz, 2H), 4.47 (t, J = 6.9 Hz, 2H), 3.05 (t, J = 6.9 Hz, 2H), 2.32 (s, 3H). 13 4-methoxyphenethyl alcohol (2 g, 1.96 mL, 16.4 mmol) was subjected to GP1. Following reaction completion, the solvent was removed in vacuo and the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield imidate S33 (4.4 g, 100%) as a colorless solid. Rf: 0.25 (10% Ethyl acetate/hexanes).
1 H NMR (400 MHz, CDCl3) δ: 8.34 (bs, 1H), 7.36 -7.31 (4H, m), 7.29 -7.26 (m, 1H), 4.54 (t, J = 6.9 Hz, 2H), 3.13 (t, J = 6.9 Hz, 2H). 13 C NMR (100 MHz, CDCl3) δ: 162.8, 137.7, 129.1, 128.5, 126.7, 91.5, 69.9, 34.8.
4-nitrophenethyl 2,2,2-trichloroacetimidate (S34)
4-nitrophenethyl alcohol (334 mg, 2 mmol) was subjected to GP1. Following reaction completion, the solvent was removed in vacuo and the crude mixture was purified (silica gel, hexanes with 1% Et3N) to yield imidate S34 (565 mg, 45%) as an off-white solid. Rf: 0.10 (10% Ethyl acetate/hexanes). 1 
pentyl (Z)-N-acetoxybenzimidate (S35)
Diethyl azodicarboxylate (297 µL, 2.1 mmol) was added slowly to a solution of Nacetoxybenzamide (340 mg, 1.9 mmol), 1-pentanol (207 µL, 1.9 mmol), and triphenylphosphine (551 mg, 2.1 mmol) in THF (10 mL) at 0 °C. The reaction mixture was then stirred for 1 hour at room temperature. The reaction solvent was removed by evaporation under reduced pressure and the residue was purified by column chromatography on silica gel (20% EtOAc/hexanes) to afford the product as a colorless oil (345 mg, 73% 
IV. Optimization
Benzimidate 1 was subjected to GP5 with the described modifications. After five hours, the mixture was cooled to room temperature, the solvent was removed in vacuo, and the crude reaction was analyzed via crude 1 H NMR.
a Yields were determined by 1 H NMR analysis using 1,2-dichloroethane as an internal standard.
S18
V. Robustness Screen
To determine the tolerance of this reaction in the presence of various functional groups, a robustness screen was conducted. We subjectively chose functional groups that we deemed to be synthetically relevant (alcohols, aldehydes, ketones, alkenes, allyl bromides) or medicinally relevant (heteroarenes, amino acids). 3, 4 All additives that were investigated are included below, including those that we were surprised to find were recovered in high yields under both conditions. Only the first five examples are included in the manuscript, since they represent the biggest different between the two conditions. Benzimidate 1 (0.1 mmol) was subjected to GP5 or the stoichiometric amination procedure, 1 with the addition of 1 equivalent of the corresponding additive (0.1 mmol). After two hours, standard was added to the reaction, an aliquot was removed, and diluted with CDCl3 for 1 H NMR analysis. The percent yield of oxazoline and additive remaining were determined with respect to internal standard. Yields were determined by 1 H NMR analysis using 1,2-dichloroethane as an internal standard.
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VI. C-H Amination
2-amino-2-(4-methoxyphenyl)ethan-1-ol (3)
Trichloroacetimidate S3 (119 mg, 0.4 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 3 (67.0 mg, 100%) as a colorless solid. 
2-amino-2-(4-fluorophenyl)ethan-1-ol (4)
Trichloroacetimidate S4 (114 mg, 0.4 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 4 (47.1 mg, 77%) as a colorless solid. Oxazoline yield by 
2-amino-2-(4-(trifluoromethyl)phenyl)ethan-1-ol (5)
Trichloroacetimidate S5 (134 mg, 0.4 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 5 (45.1 mg, 90%) as a offwhite solid. Oxazoline yield by 1 H NMR: 91%. 1 H NMR (600 MHz, CDCl3) δ: 7.61 (d, J = 8.0 Hz, 2H), 7.47 (m, J = 8.3 Hz, 2H), 4.14 (dd, J = 7.7, 4.4 Hz, 1H), 3.80 (dd, J = 10.8, 4.4 Hz, 1H), 3.60 (dd, J = 10.7, 7.9 Hz, 1H), 1.89 (bs, 3H). 13 
2-amino-2-(m-methoxyphenyl)ethan-1-ol (6)
Trichloroacetimidate S6 (119 mg, 0.4 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 6 (46.0 mg, 69%) as a colorless solid. 
2-amino-2-(m-tolyl)ethan-1-ol (7)
Trichloroacetimidate S7 (119 mg, 0.4 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 7 (67.0 mg, 83%) as a colorless solid. 
2-amino-2-(2-(trifluoromethyl)phenyl)ethan-1-ol (8)
Trichloroacetimidate S8 was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 8 (72 mg, 88%) as a white solid. Oxazoline yield by 1 H NMR: 95%. Rf: 0.31 (30% isopropanol/CH2Cl2). 
2-amino-2-(o-tolyl)ethan-1-ol (9)
Trichloroacetimidate S9 was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 9 (47 mg, 87%) as a white solid. 
2-amino-2-(2-chlorophenyl)ethan-1-ol (10)
Trichloroacetimidate S10 was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 10 (52 mg, 82%) as a white solid. Oxazoline yield by 1 H NMR: 95%. Rf: 0.17 (30% isopropanol/CH2Cl2). 1 H NMR (400 MHz, CDCl3) δ: 7.47 (dd, J = 7.7, 1.7 Hz, 1H), 7.36 (dd, J = 7.9, 1.3 Hz, 1H), 7.31 -7.27 (m, 1H), 7.21 (td, J = 7.5, 1.7 Hz, 1H), 4.51 (dd, J = 7.8, 4.0 Hz, 1H), 3.83 (dd, J = 10.7, 4.0 Hz, 1H), 3.57 (dd, J = 10.7, 7.8 Hz, 1H), 1.85 (bs, 3H). 13 C NMR (100 MHz, CDCl3) δ: 140.1, 133.2, 129.9, 128.6, 127.5, 127.3, 66.2, 53.8.
2-amino-2-(thiophen-2-yl)ethan-1-ol (11)
Trichloroacetimidate S11 (109 mg, 0.4 mmol) was subjected to GP5 with the following changes. To a 2-dram vial equipped with PTFE septa cap and magnetic stir bar was added imidate (0.4 mmol, 1 equiv.), PhI(OAc)2 (258 mg, 0.8 mmol, 2 equiv.). This vial was evacuated and backfilled with N2 (3x). A degassed stock solution of I2 in dry DMF (2 mL, 0.01 M, 0.05 equiv.) was added to the vial under N2. The reaction was heated to 50°C (by placing vial in an aluminum heating block) and stirred for 4 hours. Hydrolysis and acid/base extraction. Upon completion, the mixture was diluted with H2O (1 mL) and p-toluenesulfonic acid monohydrate (2.0 mmol, 5 equiv) was added and the reaction was allowed to stir for 1 hr. Upon completion, the reaction was poured into a separatory funnel containing a 1:1 mixture of saturated NaHCO3 and 20% Na2S2O3 (15 mL). The aqueous phase was washed with ethyl acetate (3 x 15 mL) and the combined organic solution was dried over MgSO4 and concentrated. The crude material was purified (silica gel, Hexanes → 10% ethyl acetate/hexanes) to yield trichloroacetamide 11 (80 mg, 69%) as a white solid. Oxazoline yield by 1 
4-(pyridin-2-yl)-2-(trichloromethyl)-4,5-dihydrooxazole (12)
Trichloroacetimidate S12 (107 mg, 0.4 mmol) was subjected to GP5 with the following changes. To a 2-dram vial equipped with PTFE septa cap and magnetic stir bar was added imidate (107 mg, 0.4 mmol, 1 equiv.), PhI(OAc)2 (258 mg, 0.8 mmol, 2 equiv.) and I2 (51 mg, 0.2 mmol, 0.5 equiv). This vial was quickly evacuated and backfilled with N2 (3x). A freeze-pump-thawed dry MeCN (2 mL) was added to the vial under N2. The reaction was heated to 50 °C and stirred for 4 hours under inert atmosphere. Upon completion, the reaction was diluted with CH2Cl2 (10 mL) and aqueous Na2S2O3 (10% w/w) was added. The aqueous layer was washed with CH2Cl2 (3 x 25 mL). The combined organic layer was dried over MgSO4 and concentrated. The crude product was purified (silica gel, Hexanes → 50% ethyl acetate/hexanes) to yield oxazoline 12 (75 mg, 71%) as a yellow oil. Oxazoline yield by 1 
2-amino-2-(4-isobutylphenyl)propan-1-ol (13)
Trichloroacetimidate S13 was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 13 (65 mg, 79%) as a white solid. Oxazoline yield by 1 H NMR: 85%. Rf: 0.1 (30% isopropanol/CH2Cl2). 
1-amino-2,3-dihydro-1H-inden-2-ol (14)
Trichloroacetimidate S14 was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 14 (46 mg, 78%) as a white solid. Oxazoline yield by 1 H NMR: 89%. Rf: 0.05 (30% isopropanol/CH2Cl2). 141.1, 128.1, 127.1, 125.6, 124.0, 72.8, 58 .6, 39.5.
5-methyl-4-phenyl-2-(trichloromethyl)-4,5-dihydrooxazole (15)
Trichloroacetimidate S15 was subjected to GP5. Analysis of the crude 
4-trichloroacetamidyl cholesterol (16)
Trichloroacetimidate S16 (212 mg, 0.4 mmol) was subjected to GP5 with the following changes. To a 2-dram vial equipped with PTFE septa cap and magnetic stir bar was added imidate (0.4 mmol, 1 equiv.) and PhI(OAc)2 (258 mg, 0.8 mmol, 2 equiv.) This vial was evacuated and backfilled with N2 (3x). A degassed stock solution of I2 in dry DMF (2 mL, 0.01 M, 0.05 equiv.) was added to the vial under N2. The reaction was heated to 50°C (by placing vial in an aluminum heating block) and stirred for 4 hours. Hydrolysis and acid/base extraction. Upon completion, the mixture was concentrated in a round-bottom flask, then methanol (4 mL), 2M HCl (0.8 mL), tetrabutylammonium chloride (111 mg, 0.4 mmol) were added. After stirring for 24 hours, the reaction was diluted with CH2Cl2 (10 mL) and aqueous Na2S2O3(10% w/w) was added. The aqueous layer was washed with CH2Cl2 (3 x 25 mL). The combined organic layer was dried over MgSO4 and concentrated. The crude product was purified (silica gel, Hexanes → 20% ethyl acetate/hexanes) to yield trichloroacetamide 16 (166 mg, 76%) as a white solid. 87 (m, 1H), 4.48 -4.45 (m, 1H), 3.87 -3.83 (m, 1H), 2.20 -2.13 (m, 2H), 2.05 -2.00 (m, 1H), 1.88 -1.80 (m, 3H), 1.75 -1.57 (m, 4H), 1.53 -1.11 (m, 15H) , 0.91 (d, J = 6.6 Hz, 3H), 0.87 (d, J = 2.3 Hz, 3H), 0.86 (d, J = 1.8 Hz, 3H), 0.67 (s, 3H). 13 C NMR (100 MHz, CDCl3) δ: 162.5, 137.9, 131.7, 93.1, 71.6, 60.9, 57.0, 56.2, 50.4, 42.3, 39.7, 39.6, 36.3, 36.1, 35.9, 32.3,  31.8, 28.3, 28.2, 25.7, 24.3, 24.0, 23.0, 22.7, 21 .0, 20.6, 18.9, 11.9.
N-(1-hydroxypentan-2-yl)benzamide (17)
Benzimidate 1 (77 mg, 0.4 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 17 (72.2 mg, 95%) as a colorless solid. Oxazoline yield by 1 H NMR: 95%. Rf: 0.63 (10% Methanol/dichloromethane). 
N-(4-cyclohexyl-1-hydroxybutan-2-yl)benzamide (18)
Benzimidate S18 (104 mg, 0.4 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 18 (90.4 mg, 82%) as a colorless 
N-(3-hydroxybutan-2-yl)benzamide (19)
Benzimidate S19 (134 mg, 0.4 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 19 (75.3 mg, 97%, 1:1 d.r.) 
N-(2-hydroxycyclopentyl)benzamide (20)
Benzimidate S20 (75.7 mg, 0.4 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 20 (51.7 mg, >20:1 d.r., 63%) as a colorless solid. Oxazoline yield by 1 
2-phenyl-4,5-dihydrooxazole (21)
Benzimidate S21 (59.7 mg, 0.4 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude NMR yield showed 48% amination, but the oxazoline proved volatile when DMF was being removed on rotary evaporator. Oxazoline 21 yield by 1 H NMR: 48%.
N-(6-chloro-1-hydroxyhexan-2-yl)benzamide (22)
Benzimidate S22 (96 mg, 0.4 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 22 (91.7 mg, 90%) as an off-white solid. 
2-(2-(2-phenyl-4,5-dihydrooxazol-4-yl)ethyl)isoindoline-1,3-dione (23)
Benzimidate S23 (64.5 mg, 0.2 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was purified via column chromatography (silica gel, 50% Ethyl acetate/hexanes) to give oxazoline 23 (65.1 mg, 100%) as a colorless solid. Oxazoline yield by 
N-(4,4,4-trifluoro-1-hydroxybutan-2-yl)benzamide (24)
Benzimidate S24 (96 mg, 0.4 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was subjected to the hydrolysis protocol to yield amino alcohol 24 (46.6 mg, 47%) as a yellow solid. -5-en-1-yl)-2-phenyl-4,5-dihydrooxazole (25) Benzimidate S25 (23 mg, 0.1 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was purified via column chromatography (silica gel, 10% EtOAc, Hexanes) to give oxazoline 25 (17.4 mg, 76%) as a colorless oil. 
4-(hex
4-(but-3-yn-1-yl)-2-phenyl-4,5-dihydrooxazole (26)
Benzimidate S26 (20 mg, 0.1 mmol) was subjected to GP5. Upon reaction completion, the mixture was cooled to room temperature and the solvent was removed in vacuo. The crude mixture was purified via column chromatography (silica gel, 10% EtOAc/hexanes) to give oxazoline 26 (11.2 mg, 56%) as a colorless oil. Oxazoline yield by 1 
Catalytic Amination Procedure:
To obtain this data, pentyl benzimidate 1 was subjected to a modified GP5.
To a 2-dram vial equipped with PTFE septa cap and magnetic stir bar was added imidate 1 (0.4 mmol, 1 equiv.), PhI(OAc)2 (154.6 mg, 0.48 mmol, 1.2 equiv.). This vial was evacuated and backfilled with N2 (3x). 2 mL of a degassed stock solution of I2 in dry DMF (5 mol%, 10 mol%, or 20 mol%) was added to the vial under N2. The reaction was heated to 50°C (by placing vial in an aluminum heating block). At the indicated time points, the reaction was quenched with 10% aqueous Na2S2O3 (2 mL) and then extracted with Et2O (4 x 4 mL). The crude reaction was concentrated and analyzed by 1 H NMR using an internal standard, dichloroethane (31.6 L, 1 equiv.).
Stoichiometric amination procedure was conducted according to ref. Table S1 : Crude percent yield of oxazoline determined by 1 H NMR.
S29
Figure S1: Kinetic profiles of various reaction conditions determined by 1 H NMR. To probe the selectivity of HAT with various electronic perturbations, we synthesized two benzimidate substrates with -benzylic and -tertiary hydrogen atoms. These substrates were subjected to both the catalytic conditions, and our previously reported stoichiometric conditions. In both cases, more efficient amination was observed in the catalytic system. Using superstiochiometric NaI and PhI(OAc)2 leads to competitive formation of a geminal di-iodide product-suppressing the amination yield.
 vs  competition: secondary vs benzylic C-H Catalytic: Imidate S27 was subjected to GP5. Analysis of the crude 1 H NMR (with 1 equiv. DCE standard) indicates 63% of the desired oxazoline 27a with 36% of the corresponding  aminated product 27b. Stoichiometric: Imidate S27 was subjected to the stoichiometric reaction conditions. 1 Analysis of the crude 1 H NMR (with 1 equiv. DCE standard) indicates 32% of the desired oxazoline 27a with 15% of the corresponding aminated product 27b and 10% of the di-iodinated imidate 27c.
4-benzyl-2-phenyl-4,5-dihydrooxazole (27a)
Rf: 0.31 (20% Ethyl acetate/hexanes). 1  vs  competition: secondary vs tertiary C-H Catalytic: Imidate S28 was subjected to GP5. Analysis of the crude 1 H NMR (with 1 equiv. DCE standard) indicates 60% of the desired oxazoline 28a with none of the corresponding -aminated product 28b (identified by analogy to a previously reported compound). Stoichiometric: Imidate S28 was subjected to the stoichiometric reaction conditions.
1 Analysis of the crude 1 H NMR (with 1 equiv. DCE standard) indicates 30% of the desired oxazoline 28a with 5% of the corresponding -aminated product 28b which could not be cleanly isolated and 20% of the geminal di-iodinated imidate 28c.
c. Stereochemical Probe
To probe intermediates in the reaction, cis and trans stereochemical probes were synthesized to understand both the HAT and amination. The catalytic amination results were compared to those previously observed using the stoichiometric conditions. 1 First, subjection of the cis substrate led to material decomposition with none of the desired oxazoline presumably due to the inaccessible benzylic hydrogen. This result mirrors the previous observations. For the trans diastereomer, a notable difference in diastereoselectivity was observed in the isolated oxazoline. Interestingly, in the catalytic system the alkyl iodide intermediate can be observed which was previously not present in the photolytic conditions.
Trichloroacetimidate cis-29 was subjected to GP5 and the stoichiometric reaction conditions. 
d. Hammett Plot
To determine the stabilization effect of substituents in the transition state of the 1,5-hydrogen atom transfer, a Hammett Plot analysis was conducted. Each data point in Figure S3 is represented as an average of two trials. To identify the pseudo-first order regime, the early reaction time points from Figure S1 were re-examined. Based on the data depicted in Figure S2 , a 5-minute time point was selected for Hammett analysis. 
Catalytic Amination Procedure:
To a 2-dram vial equipped with PTFE septa cap and magnetic stir bar was added imidate (0.4 mmol, 1 equiv.) and PhI(OAc)2 (154.6 mg, 0.48 mmol, 1.2 equiv.). This vial was evacuated and backfilled with N2 (3x). A degassed stock solution of I2 in dry DMF (2 mL, 0.01 M, 0.05 equiv.) was added to the vial under N2. The reaction was heated to 50 °C (by placing vial in an aluminum heating block). After 5 minutes, the reaction was quenched with 10% aqueous Na2S2O3 (2 mL) and then extracted with Et2O (4 x 4 mL). The crude reaction was concentrated and analyzed by 1 H NMR using an internal standard, dichloroethane (31.6 L, 1 equiv.). To probe the mechanism of this reaction, possible intermediates were synthesized. In the event that N-OAc, instead of N-I benzimidate, is formed via AcO-I, N-acetoxybenzimidate S35 was synthesized. The oxime imidate S35 was subjected to our catalytic amination condition, which resulted in full recovery of S35, indicating this is unlikely to be an intermediate. Additionally, S35 is stable in refluxing DMF for 2 hrs.
Oxime Imidate S35 was subjected to GP5. Analysis of the crude 1 H NMR (with 1 equiv. DCE standard) indicates no oxazoline and full recovery of oxime imidate starting material.
Oxime Imidate S35 was heated in DMF at 100 °C for 2 hrs. Analysis of the crude 1 H NMR (with 1 equiv. DCE standard) indicates no oxazoline and full recovery of oxime imidate starting material.
